Civeo Corp: Stifel raises target price to $42 from $37
CVEO•Stifel raised its target price for Civeo Corp to $42 from $37.
Related News
Why SocGen likes European pharma
XLV•
US government websites lag in post-quantum cryptography adoption at 42.7%, F5 finds
FFIV•
UroGen Pharma presents at Guggenheim Securities healthcare innovation conference
URGN•
Cipher Digital target price cut to $19 from $30 by Rosenblatt Securities
CIFR•
Neurogene to participate in Guggenheim and Stifel healthcare conferences
NGNE•